A comprehensive study of effective responses as well as resistant responses to a kidney cancer anti-PD-1 therapy found specific immune features that could provide new targets to improve cancer treatment, say findings published in Cancer Discovery.
A comprehensive study of effective responses as well as resistant responses to a kidney cancer anti-PD-1 therapy found specific immune features that could provide new targets to improve cancer treatment, say findings published in Cancer Discovery.
Leave A Comment